FDA Warns Companies to, Stop Selling Potentially Dangerous, , Unapproved Eye Drops.<br />Gizmodo reports that the United States Food and <br />Drug Administration (FDA) has warned several companies <br />to stop selling unapproved eye drop products.<br />On September 12, the FDA announced that it had <br />issued warning letters to eight companies <br />regarding the potentially dangerous products.<br />The companies, including major retail chains CVS and <br />Walgreens, have allegedly committed a number of <br />violations by marketing or manufacturing these products.<br />The companies, including major retail chains CVS and <br />Walgreens, have allegedly committed a number of <br />violations by marketing or manufacturing these products.<br />The companies, including major retail chains CVS and <br />Walgreens, have allegedly committed a number of <br />violations by marketing or manufacturing these products.<br />The FDA has also expressed concerns over silver <br />compounds found in some of the products, which can <br />turn people's skin or eyes blue with long-term use.<br />According to the FDA, some of the eye drop products <br />were allegedly manufactured at facilities that have <br />failed to meet standard safety and quality guidelines.<br />The FDA is particularly concerned that these <br />illegally marketed, unapproved ophthalmic <br />drug products pose a heightened <br />risk of harm to users because drugs <br />applied to the eyes bypass some <br />of the body’s natural defenses, Food and Drug Administration, via statement.<br />The FDA is particularly concerned that these <br />illegally marketed, unapproved ophthalmic <br />drug products pose a heightened <br />risk of harm to users because drugs <br />applied to the eyes bypass some <br />of the body’s natural defenses, Food and Drug Administration, via statement.<br />Gizmodo reports that the companies <br />have 15 days to respond with their <br />plans to correct the alleged violations.<br />If the companies fail to respond, the FDA could <br />take further action to either seize or stop the <br />manufacturing of the products in question.<br />When we identify illegally marketed, <br />unapproved drugs and lapses in drug <br />quality that pose potential risks, <br />the FDA works to notify the <br />companies involved of the violations, Jill Furman, Director of the Office of Compliance for the FDA’s <br />Center for Drug Evaluation and Research, via Gizmodo.<br />We will continue to investigate potentially <br />harmful eye products and work to ensure <br />violative products stay off store shelves <br />so that consumers can continue taking <br />the medicines they need without concern, Jill Furman, Director of the Office of Compliance for the FDA’s <br />Center for Drug Evaluation and Research, via Gizmodo.<br />We will continue to investigate potentially <br />harmful eye products and work to ensure <br />violative products stay off store shelves <br />so that consumers can continue taking <br />the medicines they need without concern, Jill Furman, Director of the Office of Compliance for the FDA’s <br />Center for Drug Evaluation and Research, via Gizmodo
